Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 43 | $40,077,400 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 20 Mar 2025 19:38 | BMRN | BIOMARIN PHARMACEUTICAL INC | BURKHART ERIN | GVP, Chief Accounting Officer | 19 Mar 2025 | Sale | 1,295 | 71.52 | 92,618 | D |
| 07 Mar 2025 16:06 | BMRN | BIOMARIN PHARMACEUTICAL INC | GUYER CHARLES GREG | EVP, Chief Technical Officer | 06 Mar 2025 | Sale | 7,034 | 71.276 | 501,355 | D |
| 25 Feb 2025 20:21 | BMRN | BIOMARIN PHARMACEUTICAL INC | BURKHART ERIN | GVP, Chief Accounting Officer | 24 Feb 2025 | Sale | 1,344 | 68.38 | 91,903 | D |
| 14 Nov 2024 14:44 | BMRN | BIOMARIN PHARMACEUTICAL INC | GUYER CHARLES GREG | EVP, Chief Technical Officer | 12 Nov 2024 | Sale | 5,278 | 66.3743 | 350,324 | D |
| 15 Aug 2024 15:57 | BMRN | BIOMARIN PHARMACEUTICAL INC | BURKHART ERIN | GVP, Chief Accounting Officer | 13 Aug 2024 | Sale | 714 | 90 | 64,260 | D |
| 31 May 2024 18:28 | BMRN | BIOMARIN PHARMACEUTICAL INC | MUELLER BRIAN | EVP, Chief Financial Officer | 30 May 2024 | Sale | 5,000 | 75.19 | 375,950 | D |
| 30 May 2024 18:18 | BMRN | BIOMARIN PHARMACEUTICAL INC | DAVIS GEORGE ERIC | EVP, Chief Legal Officer | 28 May 2024 | Sale | 2,779 | 75.288 | 209,225 | D |
| 30 May 2024 18:18 | BMRN | BIOMARIN PHARMACEUTICAL INC | DAVIS GEORGE ERIC | EVP, Chief Legal Officer | 28 May 2024 | Sale | 38,071 | 74.455 | 2,834,576 | D |
| 13 May 2024 15:57 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 10 May 2024 | Sale | 20,000 | 81.14 | 1,622,800 | D |
| 13 May 2024 15:57 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 09 May 2024 | Sale | 20,000 | 81.62 | 1,632,400 | D |
| 06 May 2024 16:45 | BMRN | BIOMARIN PHARMACEUTICAL INC | DAVIS GEORGE ERIC | EVP, Chief Legal Officer | 02 May 2024 | Sale | 1,850 | 85.01 | 157,268 | D |
| 06 May 2024 16:40 | BMRN | BIOMARIN PHARMACEUTICAL INC | AJER JEFFREY ROBERT | EVP, Chief Commercial Officer | 02 May 2024 | Sale | 5,000 | 82.91 | 414,550 | D |
| 15 Apr 2024 16:21 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 12 Apr 2024 | Sale | 20,000 | 91.26 | 1,825,200 | D |
| 15 Apr 2024 16:21 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 11 Apr 2024 | Sale | 20,000 | 90.99 | 1,819,800 | D |
| 12 Apr 2024 15:07 | BMRN | BIOMARIN PHARMACEUTICAL INC | BURKHART ERIN | GVP, Chief Accounting Officer | 10 Apr 2024 | Sale | 2,286 | 90 | 205,740 | D |
| 01 Apr 2024 16:54 | BMRN | BIOMARIN PHARMACEUTICAL INC | DAVIS GEORGE ERIC | EVP, Chief Legal Officer | 28 Mar 2024 | Sale | 24,602 | 88.34 | 2,173,341 | D |
| 07 Mar 2024 18:54 | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | President, Worldwide R&D | 05 Mar 2024 | Sale | 35,341 | 85.1814 | 3,010,396 | D |
| 07 Mar 2024 17:35 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 06 Mar 2024 | Sale | 1,000 | 86.713 | 86,713 | D |
| 07 Mar 2024 17:35 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 05 Mar 2024 | Sale | 1,000 | 85.51 | 85,510 | D |
| 07 Mar 2024 17:32 | BMRN | BIOMARIN PHARMACEUTICAL INC | AJER JEFFREY ROBERT | EVP, Chief Commercial Officer | 05 Mar 2024 | Sale | 4,000 | 87.07 | 348,280 | D |
| 29 Feb 2024 17:05 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 27 Feb 2024 | Sale | 1,000 | 90.35 | 90,350 | D |
| 12 Feb 2024 17:20 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 08 Feb 2024 | Sale | 15,000 | 89.77 | 1,346,550 | D |
| 12 Feb 2024 17:20 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 09 Feb 2024 | Sale | 15,000 | 88.28 | 1,324,200 | D |
| 11 Jan 2024 14:40 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 10 Jan 2024 | Sale | 10,000 | 96.38 | 963,800 | D |
| 11 Jan 2024 14:40 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 09 Jan 2024 | Sale | 10,000 | 98.19 | 981,900 | D |
| 22 Dec 2023 17:14 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 21 Dec 2023 | Sale | 10,000 | 93.99 | 939,900 | D |
| 14 Dec 2023 18:18 | BMRN | BIOMARIN PHARMACEUTICAL INC | DAVIS GEORGE ERIC | EVP, Chief Legal Officer | 13 Dec 2023 | Sale | 13,764 | 95.3 | 1,311,709 | D |
| 17 Aug 2023 15:57 | BMRN | BIOMARIN PHARMACEUTICAL INC | AJER JEFFREY ROBERT | EVP, Chief Commercial Officer | 16 Aug 2023 | Sale | 5,000 | 90 | 450,000 | D |
| 11 Aug 2023 13:59 | BMRN | BIOMARIN PHARMACEUTICAL INC | FUCHS HENRY J | President, Worldwide R&D | 10 Aug 2023 | Sale | 12,000 | 90.4259 | 1,085,111 | D |
| 10 Aug 2023 16:47 | BMRN | BIOMARIN PHARMACEUTICAL INC | GUYER CHARLES GREG | EVP, Chief Technical Officer | 09 Aug 2023 | Sale | 5,360 | 93.304 | 500,109 | D |
| 09 Aug 2023 19:08 | BMRN | BIOMARIN PHARMACEUTICAL INC | DAVIS GEORGE ERIC | EVP, Chief Legal Officer | 08 Aug 2023 | Sale | 11,000 | 89.4238 | 983,662 | D |
| 09 Aug 2023 19:05 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 08 Aug 2023 | Sale | 6,000 | 88.29 | 529,740 | D |
| 09 Aug 2023 19:05 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 07 Aug 2023 | Sale | 4,000 | 88.1 | 352,400 | D |
| 15 May 2023 16:58 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 11 May 2023 | Sale | 5,561 | 95.22 | 529,518 | D |
| 15 May 2023 16:58 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 11 May 2023 | Sale | 24,439 | 94.55 | 2,310,707 | D |
| 11 May 2023 17:04 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 10 May 2023 | Sale | 8,547 | 95.34 | 814,871 | D |
| 11 May 2023 17:04 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 10 May 2023 | Sale | 21,453 | 94.65 | 2,030,526 | D |
| 11 May 2023 17:04 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 09 May 2023 | Sale | 1,410 | 95.9 | 135,219 | D |
| 11 May 2023 17:04 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 09 May 2023 | Sale | 14,964 | 95.49 | 1,428,912 | D |
| 11 May 2023 17:04 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 09 May 2023 | Sale | 13,626 | 94.22 | 1,283,842 | D |
| 12 Apr 2023 16:08 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 10 Apr 2023 | Sale | 10,000 | 99.56 | 995,600 | D |
| 10 Apr 2023 19:00 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 06 Apr 2023 | Sale | 10,000 | 96.13 | 961,300 | D |
| 04 Apr 2023 19:59 | BMRN | BIOMARIN PHARMACEUTICAL INC | LAWLIS V BRYAN | Director | 03 Apr 2023 | Sale | 8,500 | 97.09 | 825,265 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)